ZVR 300 (Zidovudine 300 mg)
Pill with imprint ZVR 300 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Cipla Ltd.
Zidovudine is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZVR 300
Zidovudine
- Imprint
- ZVR 300
- Strength
- 300 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla Ltd.
- National Drug Code (NDC)
- 53104-0101
- Inactive Ingredients
-
sodium starch glycolate type A potato,
microcrystalline cellulose,
corn starch,
magnesium silicate,
magnesium stearate,
hypromelloses,
silicon dioxide
Note: Inactive ingredients may vary.
More about zidovudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Drug images
- Pricing & coupons
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Drug Information
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Injection
- Zidovudine Syrup
- Other brands
- Retrovir
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.